FDA claims there’s no estrogen patch shortage as women struggle to get prescriptions filled - BERITAJA

The Food and Drug Administration removed the achromatic container informing from hormone replacement therapies precocious past year, and recently, the about insured type, the estrogen patch, has been successful short proviso amid a roar successful the therapy’s popularity.

“There’s been a surge successful request for the past 2 aliases 3 years wherever the utilization of transdermal estrogen has gone up significantly,” said Dr. Robert Kauffman, a professor of obstetrics and gynecology astatine Texas Tech Physicians of Amarillo.

While doctors and patients study difficulties getting definite doses of estrogen patches, the FDA has not yet included immoderate connected its list of narcotics successful shortage.

FDA main Dr. Marty Makary said Tuesday that the agency’s move to remove the achromatic container informing label for hormone therapy successful November prompted a tremendous summation successful request for estrogen patches, but not capable to origin a shortage.

“The manufacture has been capable to support up but barely,” Makary said successful an interview. “They are recalibrating their distribution and manufacturing to person much robust supply. In the interim, the estrogen patches person not risen to the criteria of being connected the shortage list, but it is thing to manage.”

Being included connected the FDA shortage database is important because it could thief trigger actions specified arsenic identifying replacement suppliers and extending expiration dates for drugs.

Hormone replacement medications are prescribed to dainty basking flashes, temper swings, urinary tract infections, vaginal dryness and trouble sleeping, and to protect against bony fractures. They could either beryllium estrogen-only aliases progesterone-only aliases a operation of estrogen and progesterone — the superior female activity hormones.

Is location an estrogen spot shortage?

There’s not 1 answer.

The American Society of Health-System Pharmacists, a master statement for pharmacists, includes 14 brands aliases dosages of estrogen patches successful its about existent list of narcotics successful shortage. The group first started including estrogen patches connected the database successful January.

“Our database is 100% reported by either practitioners, pharmacists, physicians, nurses aliases patients and caregivers,” said Michael Ganio, the elder head of drugstore believe and value astatine ASHP, which collects information successful business pinch the University of Utah Health.

Dr. Lauren Streicher, a professor of obstetrics and gynecology astatine the Northwestern University Feinberg School of Medicine successful Chicago, said estrogen spot shortages ever travel up erstwhile she speaks pinch groups of women about menopause.

Dr. Kathleen Jordan, the main aesculapian serviceman astatine Midi Health, a telehealth institution that specializes successful menopause, besides said patients are progressively facing problems erstwhile filling estrogen spot prescriptions “due to shortages astatine the pharmacies.”

“This was happening occasionally past twelvemonth but has escalated this year,” she said.

Kauffman, the Texas gynecologist, said there’s a shortage successful West Texas and colleagues “all complete the country” are reporting them arsenic well.

On the different hand, a spokesperson for Alloy Health, a menopause telehealth company, said successful an email that it has not noticed an estrogen spot shortage affecting its patients.

Meanwhile, the FDA relies connected historical request information to find if supplier companies are keeping up pinch demand, truthful its accusation connected existent increases successful request whitethorn beryllium lagging, Ganio said. An FDA spokesperson said if the nationalist proviso falls into shortage, it’ll beryllium posted connected the agency’s drug shortage website.

Swiss generics shaper Sandoz told Reuters successful April that the institution has shipped further supplies to the U.S. to thief pharmacies support up pinch demand. Beritaja reached retired to 4 estrogen spot manufacturers about the shortage successful May — Viatris, Sandoz, Noven Pharmaceuticals and Amneal Pharmaceuticals — but didn’t person a response.

“We are assuming based connected everything we cognize this is caused by accrued demand, but without a shaper saying ‘We are having a proviso issue,’ we can’t opportunity that for sure,” Ganio said.

What is driving demand?

After the highly publicized Women’s Health Initiative study successful 2002 linked hormone therapy to accrued consequence of bosom cancer, bosom attacks and strokes successful postmenopausal women, prescriptions plummeted among menopausal women successful the U.S., from 22% to 5% complete the adjacent decade. Even aft caller grounds recovered the consequence was chiefly successful women who were older erstwhile they started hormone therapy, the cognition that it was vulnerable persisted until caller years.

From 2018 to 2026, the number of women ages 45 to 54 who were prescribed estrogen-based therapies accrued by 184%, according to a caller survey by Truveta, a wellness attraction analytics company. Prescriptions accrued by 20% betwixt July 2025 and February 2026 alone.

Not only has request surged, there’s been a alteration successful really women usage the medications.

Jordan, of Midi Health, said women are utilizing hormone therapy longer than successful the past, adding to the summation successful demand.

Guidelines utilized to urge women only beryllium connected hormone therapy for menopause for 5 to 10 years, and extremity by property 60, but newer studies suggest women could use from starting hormone therapy earlier — often successful their 40s — and enactment connected it into their 60s, 70s aliases 80s, Jordan said successful an email.

“This intends much women going to the drugstore for refills,” she said.

The refills are typically for estrogen patches — versus different types of hormone therapy specified arsenic creams aliases vaginal rings — because estrogen patches are typically cheaper than the alternatives, person the largest magnitude of information information and are much apt to beryllium covered by insurance, Kauffman said.

When will estrogen spot supplies rebound?

It’s unclear.

Although supplier companies look to beryllium ramping up production, immoderate estrogen patches could stay successful shortage for years.

Dr. Stephanie Faubion, head of the Mayo Clinic’s Center for Women’s Health, is simply a spot much optimistic.

“No 1 knows precisely erstwhile the shortage will beryllium over, but companies are expanding production, truthful things should beryllium amended by the extremity of the year,” Faubion said successful an email.

Since pharmaceutical companies typically make narcotics and therapies successful batches and scheme those batches months successful advance, immoderate companies whitethorn not beryllium capable to summation estrogen spot accumulation for a fewer months, Ganio said.

In the coming months, manufacturers “will surely effort to boost output,” Ganio said.

What are the alternatives?

Some women whitethorn beryllium capable to move to a different marque aliases deterioration 2 patches of a little dose if their regular medicine is unavailable, said Faubion, who is besides the aesculapian head of The Menopause Society.

There are besides different forms of estrogen: topical creams and gels, oral and vaginal rings. Patches travel successful 2 types, 1 that is changed doubly per week and 1 that is swapped conscionable once, truthful changing betwixt the 2 options could besides thief women enactment connected estrogen patches moreover if their accustomed marque and dose is successful short supply, Faubion said.

“I person not had a diligent yet that we haven’t recovered an replacement for,” Faubion said.

The alternatives include:

Oral estrogen

Oral estrogen has been shown to lower harmful LDL cholesterin and summation protective HDL cholesterol, which could make it the champion action for women who person precocious cholesterol, Northwestern’s Streicher said. Women who person a history of humor clots should debar taking oral estrogen, since it could somewhat raise clotting risk.

Vaginal ringing

Localized estrogen delivered done a vaginal ringing could thief women who struggle pinch vaginal dryness aliases recurrent urinary tract infections, but a vaginal ringing could besides present systemic estrogen, Streicher said.

Transdermal estrogen

Gels, creams and patches each autumn into a class called transdermal estrogen.

“In position of safety, they are each equal,” Streicher said. However, “the nonpatch options are little apt to beryllium covered by insurance.”